Form 4 for NEO NEOGENOMICS INC
Accepted 2025-05-13 00:00:00 ET · period of report 2025-05-11 · accession 0001077183-25-000105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-13 | 2025-05-11 | NEO | Sherman Jeffrey Scott | CFO | M - OptEx | $0.00 | +13.0K | 171.5K | +8% | $0 |
| D | 2025-05-13 | 2025-05-11 | NEO | Sherman Jeffrey Scott | CFO | F - Tax | $0.00 | -3,167 | 168.3K | -2% | $0 |
| D | 2025-05-13 | 2025-05-11 | NEO | Sherman Jeffrey Scott | CFO | M - OptEx | $0.00 | -13.0K | 13.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-11 | M | A | 13,005 | $0.00 | 171,499 | D | — | — | (F1) Each restricted stock unit is the economic equivalent of NeoGenomics common stock and is converted into common stock upon vesting. |
| 2 | Common | Common Stock | 2025-05-11 | F | D | 3,167 | $0.00 | 168,332 | D | — | — | (F2) Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. |
| 3 | Derivative | Restricted Stock Unit | 2025-05-11 | M | D | 13,005 | $0.00 | 13,006 | D | $0.00 · — to — | 13,005 Common Stock | (F3) On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. (F4) Once vested, the shares of common stock are not subject to expiration. |